Wells Fargo Increases PT on The Pennant Group Stock, Keeps Equal Weight Rating

The Pennant Group, Inc. (NASDAQ:PNTG) is one of the 12 Small Cap Stocks with High Upside Potential. On June 3, Wells Fargo increased the price target on The Pennant Group stock from $30 to $31, keeping its Equal Weight rating on the shares.

Stephen Baxter from Wells Fargo raised the price target on PNTG, citing the company’s strong Q1 2025 growth across its key segments. The company’s Home Health and Hospice segment outperformed with a record-setting quarter, with a 37.2% rise in revenue and a 40.6% growth in adjusted EBITDA.

Baxter expects the company to perform well, aligning with high-end 2025 guidance and a positive update on the Signature integrating process. The company has integrated 36 new operations since January 2024, with many acquisitions performing above initial expectations.

The Pennant Group, Inc. (NASDAQ:PNTG) offers healthcare services in the U.S. and operates through two segments, including Home Health and Hospice Services, and Senior Living Services.

While we acknowledge the potential of PNTG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.